Msn Laboratories - Api Division

Msn Laboratories - Api Division company information, Employees & Contact Information

Established in the Year of 2003, MSN is the leading manufacturer of the Active Pharmaceutical Ingredients with 800+ clients spreading across the Globe. The MSN's API portfolio consist of 400+ APIs which covers the widest range of therapeutic categories. To bolster it's legacy API business, MSN is producing it's active Ingredients across 11 state-of-the-art manufacturing facilities having the total 4000+ work force across all the manufacturing sites . The World Class Integrated research Center housing the 1000+ skilled manpower to deliver the 40+ new APIs every year.

Company Details

Employees
263
Address
Hyderabad, Telangana 500018, In
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
HYDERABAD, Telangana
Looking for a particular Msn Laboratories - Api Division employee's phone or email?

Msn Laboratories - Api Division Questions

News

Novadoz Pharmaceuticals' Corporate Group Entity, MSN Pharmaceuticals Inc., Has Received USFDA Clearance for its State-of-the-Art Manufacturing Facility in Piscataway, NJ - BioSpace

Novadoz Pharmaceuticals' Corporate Group Entity, MSN Pharmaceuticals Inc., Has Received USFDA Clearance for its State-of-the-Art Manufacturing Facility in Piscataway, NJ BioSpace

MSN Laboratories Earns Great Place to Work® Certification: A Celebration of Its People - PR Newswire

MSN Laboratories Earns Great Place to Work® Certification: A Celebration of Its People PR Newswire

MSN Labs eyes acquisitions in CDMO, generics space - Times of India

MSN Labs eyes acquisitions in CDMO, generics space Times of India

MSN Labs launches a new drug for percutaneous coronary intervention - Chennai Patrika

MSN Labs launches a new drug for percutaneous coronary intervention Chennai Patrika

Novadoz Pharmaceuticals Wins Approval for Several New Products in 2022 Including Products Manufactured in its new US based plant - BioSpace

Novadoz Pharmaceuticals Wins Approval for Several New Products in 2022 Including Products Manufactured in its new US based plant BioSpace

Hyderabad-based MSN Labs to begin phase III trial of Molnupiravir - Telangana Today

Hyderabad-based MSN Labs to begin phase III trial of Molnupiravir Telangana Today

Novadoz Pharmaceuticals/MSN Labs is granted FDA Approval of generic Febuxostat Tablets, begins immediate shipping - PR Newswire

Novadoz Pharmaceuticals/MSN Labs is granted FDA Approval of generic Febuxostat Tablets, begins immediate shipping PR Newswire

MSN Labs ties up with Eli Lilly for baricitinib in India - The Economic Times

MSN Labs ties up with Eli Lilly for baricitinib in India The Economic Times

News On Click - Global Prime News

News On Click Global Prime News

MSN Labs enters into License Agreement with DRDO for 2 DG - Chennai Patrika

MSN Labs enters into License Agreement with DRDO for 2 DG Chennai Patrika

Novadoz Pharmaceuticals/MSN Labs gains FDA approval and commences shipping of Pregabalin capsules, the largest generic product launch of the year - PR Newswire

Novadoz Pharmaceuticals/MSN Labs gains FDA approval and commences shipping of Pregabalin capsules, the largest generic product launch of the year PR Newswire

MSN Labs launches Empagliflozin tablets for diabetes management - Telangana Today

MSN Labs launches Empagliflozin tablets for diabetes management Telangana Today

MSN Labs/Novadoz Pharmaceuticals Early Success Continues With FDA Approval Of Generic Abiraterone - PR Newswire

MSN Labs/Novadoz Pharmaceuticals Early Success Continues With FDA Approval Of Generic Abiraterone PR Newswire

Novadoz Has a Fast Start to 2021 with Generic Launches of Albendazole, Droxidopa, Deferasirox Granules, and Pregabalin ER - PR Newswire

Novadoz Has a Fast Start to 2021 with Generic Launches of Albendazole, Droxidopa, Deferasirox Granules, and Pregabalin ER PR Newswire

Breckenridge Pharmaceutical, Inc. Announces Launch of Lacosamide Tablets, USP (generic version of Vimpat®) Manufactured by MSN Laboratories Private Limited - PR Newswire

Breckenridge Pharmaceutical, Inc. Announces Launch of Lacosamide Tablets, USP (generic version of Vimpat®) Manufactured by MSN Laboratories Private Limited PR Newswire

Novadoz Receives Marketing Approval for Generic Versions of Rosuvastatin, Capecitabine, & Moxifloxacin - PR Newswire

Novadoz Receives Marketing Approval for Generic Versions of Rosuvastatin, Capecitabine, & Moxifloxacin PR Newswire

Top Msn Laboratories - Api Division Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant